-
$3.5 million per dose! FDA approves Pfizer's one-time gene therapy for hemophilia B
On Friday Eastern Time, US pharmaceutical giant Pfizer announced that the US Food and Drug Administration (FDA) has approved a gene therapy for treating hemophilia, making it the first gene therapy a ...